9th Annual Biomarkers Congress
25th February 2014 — 26th February 2014
The congress will cover the latest advances in biomarker discovery, development and verification; focusing on breakthrough technologies and case studies from leading pharmaceutical organisations.
The increasing interest in biomarker discovery in recent years has pushed biomarker research into the foreground of the modern pharmaceutical industry. New identification technologies have both widened the scope of biomarker research and underlined the need for robust validation, improved predictive value and the clear demonstration of clinical relevance.
The Biomarkers Congress will cover the latest advances in biomarker discovery and verification, including multiplex platforms, nanotechnology platforms and multiple reaction monitoring. Our expert speakers will also discuss efforts to increase biomarker sensitivity and specificity through genomic analysis, systems biology approaches and better sample management. In the Companion Diagnostics stream, presentations will cover Rx/Dx co-development, methods to increase predictive significance and regulatory considerations.
To build on the clinical case studies shared at last year’s event, we are pleased to introduce the co-located ‘Biomarkers in Clinical Development Congress’, focusing on the role of biomarkers in clinical decision making, drug efficacy prediction and clinical safety. Key decision makers in personalised medicine will complement these discussions with their insights into adaptive trial design, patient stratification and markers for improved treatment response.
The event features over 50 presentations from key decision makers in the biomarker industry, speaking to an audience of over 250 senior peers working in biomarker research, personalised healthcare and companion diagnostics. To celebrate the event’s long-standing association with the city of Manchester, the 2014 Biomarkers Congress will be held at Old Trafford. Registration at the congress will include an exclusive guided tour through the home of Manchester United.
To download the agenda please click here.
For information on prices please contact Danielle Dalby on email@example.com or call +44 (0)1865 248455
Senior level attendees from leading pharmaceutical, biopharmaceutical, biotechnology, diagnostics, CRO and solution provider companies, along with highly esteemed members of academic and government institutions.
Expected Number of Attendees
View Conference Website: 9th Annual Biomarkers Congress
Price of Attendance
Discounted prices available
United Arab Emirates